12:00 AM
 | 
Jul 29, 2013
 |  BC Week In Review  |  Company News  |  Other News

Novartis pharmaceuticals news

Novartis said its board reached a final agreement with Honorary Chairman Daniel Vasella, who departed as chairman in February. In exchange for his services during the transition period from Feb. 22, 2013 to Oct. 31, 2013, Vasella will...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >